Literature DB >> 1078681

Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. I. Population studies.

I F McKenzie, G D Snell.   

Abstract

The Ly-4 locus defines an alloantigenic specificity present on the surface of lymphocytes of some mouse strains and detected in lymphocytotoxicity tests by an antiserum (BALB/c times SWR)F1 anti-B10.D2. In this paper are presented results which indicate that Ly-4.2 is predominantly represented on B cells and not T cells. In cytotoxicity tests with rabbit complement, the distribution of Ly-4.2 is restricted: thymus 5%, TDL 12%, spleen 60%, lymph node 30%, bone marrow 36%, Peyer's patches 55%, peritoneal exudate cells 35%, and peripheral lymphocytes 35%. This distribution is the reciprocal of that obtained with anti-Thy-1 antiserum. Further, when both reagents were used together, almost all cells in these tissues were lysed, excepting those with bone marrow. When anti-Ly-4.2 and anti-Thy-1.2 were used sequentially, it was apparent that these specificities were present on different cell populations. As Thy-1 is a marker for T cells, Ly-4 is therefore, presumably, a marker for B cells. This conclusion was confirmed by testing mice depleted of T cells ("nude"; thymectomy + anti-lymphocyte serum treatment; thymectomy, irradiation + reconstitution with bone marrow) where the majority of lymphocytes were Ly-4.2+, Thy-1.2-; and by testing tumors, where, for the most part, this reciprocal relationship held true. Appropriate studies indicate that the Ly-4.2 antibody does not detect a surface immunoglobulin allotype. Anti-Ly-4.2 anti-serum may provide a useful alloantigenic marker distinct from immunoglobulin, mouse-specific bone marrow-derived lymphocyte anti;en, and "beta" for detecting some or all, B cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078681

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  An Ly-like specificity with extensive nonlymphoid expression.

Authors:  P F Halloran; D Dutton; H Chance; Z Cohen
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

2.  Gm-3.2, a new granulocyte/macrophage alloantigen.

Authors:  M L Hibbs; P M Hogarth; R A Harris; I F McKenzie
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

3.  A monoclonal antibody detecting the Ly-9.2 (Lgp 100) cell-membrane alloantigen.

Authors:  P M Hogarth; J Craig; I F McKenzie
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

4.  Multiplicity of chromosome 2 histocompatibility genes: new loci, H-44 and H-45.

Authors:  R J Graff; D Martin-Morgan; M E Kurtz
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

5.  A new murine alloantigen: Ly-26.1.

Authors:  P M Hogarth; S E Latham; I F McKenzie
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

Review 6.  Genetics of beta-2 microglobulin in the mouse.

Authors:  J Michaelson
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

7.  Definition of new alloantigens encoded by genes in the Ly-6 complex.

Authors:  P M Hogarth; B A Houlden; S E Latham; V R Sutton; I F McKenzie
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

8.  Genetic polymorphism of beta 2-microglobulin (B2m) maps to the H-3 region of chromosome 2.

Authors:  J Michaelson
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

9.  Monoclonal antibodies to the murine Ly-2.1 cell surface antigen.

Authors:  P M Hogarth; J Edwards; I F McKenzie; J W Goding; F Y Liew
Journal:  Immunology       Date:  1982-05       Impact factor: 7.397

10.  The surface phenotype of a suppressor cell of delayed-type hypersensitivity in the mouse.

Authors:  C H Thompson; T A Potter; I F McKenzie; C R Parish
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.